American Academy of Orthopaedic Surgeons, March 2-6
Medically reviewed by Drugs.com
via HealthDayThe annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) was held from March 2 to 6 in New Orleans. The conference highlighted recent advances in the diagnosis and management of musculoskeletal conditions, with presentations focusing on joint fractures, osteoarthritis, other musculoskeletal injuries, and factors impacting the outcomes of joint replacement procedures.
During the meeting, Virginia orthopedic surgeon Wilford K. Gibson, M.D., was announced as the new AAOS president. "AAOS is strongest when we work together to engage our members, serve our profession, and advocate for our patients," Gibson said in a statement. "I look forward to leading with a service-driven mindset that strengthens our culture, amplifies our collective voice, and advances excellence in musculoskeletal care."
AAOS: Early Youth Sport Specialization Tied to Hip Issues in Young Adulthood
TUESDAY, March 10, 2026 -- Repetitive stress from early single-sport specialization is associated with increases in hip problems and surgery in young adulthood, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.
AAOS: 2017 to 2023 Saw Surge in E-Bike Injuries in Youth
FRIDAY, March 6, 2026 -- E-bike injuries requiring trauma activation dramatically increased among youth from 2017 to 2023, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.
AAOS: GLP-1 Receptor Agonist Use Increases Five-Year Risk for Osteoporosis
FRIDAY, March 6, 2026 -- Treatment with glucagon-like peptide-1 receptor agonists for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared with nonuse, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.
AAOS: Greater QOL, Higher Satisfaction Seen With Robotic-Assisted TKA
THURSDAY, March 5, 2026 -- Robotic-assisted total knee arthroplasty is associated with higher satisfaction and greater improvement in quality of life than conventional total knee arthroplasty, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.
AAOS: Complications More Likely With Pre-TKA Testosterone Replacement Therapy Use
THURSDAY, March 5, 2026 -- Testosterone replacement therapy before total knee arthroplasty is associated with an increased risk for medical and periprosthetic complications, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-13 01:48
Read more
- Fitness Trackers Might Help Predict Multiple Sclerosis Progression
- FDA Approves Bysanti (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia
- Many Seniors Gain Physical, Mental Fitness As They Age, Study Finds
- Plant-Based Diets May Aid Symptoms of Psoriasis
- Novo Nordisk Cuts Prices of Ozempic and Wegovy Starting January 2027
- Calquence Plus Venetoclax Approved in the US as First All-Oral, Fixed-Duration Combination for Patients with Chronic Lymphocytic Leukemia in the 1st-Line Setting
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions